Johnson & Johnson at AAPS 2026 PharmSci 360

Oct 25–28, 2026 New Orleans, LA ~4k attendees Website

Johnson & Johnson brings 4 presentations to AAPS 2026 PharmSci 360 in New Orleans. Its program centres on bioanalysis, from multiplex LC-MS for several antibody drugs to oligonucleotides and their conjugates. Its sessions also cover cell therapy kinetics, tracking how living drugs spread, expand and persist in the body.

Organization	AAPS 2026 PharmSci 360 Attendance
Johnson & Johnson New Brunswick, NJ
jnj.com Large pharma Global healthcare company whose Innovative Medicine business develops and markets prescription drugs.	Talk Mon Oct 26 10:00am–10:30am Part of Symposium: Biodistribution and Persistence as the New Exposure Science for Gene & Cell Therapies: From Vectors to Living Drugs Quantifying the “Living Drug”: Integrating Biodistribution, Expansion, and Persistence into Actionable Cellular Kinetics 206 Preclinical, Clinical, and Translational Sciences Talk Mon Oct 26 3:15pm–3:30pm Part of Rapid Fire: Pushing the Boundaries of Hybrid LC-MS Bioanalysis Multiplex Hybrid LC-MS for Four Monoclonal Antibody Therapeutics 203-205 Bioanalytics Session Tue Oct 27 9:00am–11:00am Symposium: Oligonucleotide Bioanalysis: Ring Trial and Emerging Conjugate Modalities Bioanalytics Talk Tue Oct 27 1:30pm–2:30pm Keynote: Converging Platforms and Expanding Biological Insight 211-213 Bioanalytics

Organization

AAPS 2026 PharmSci 360 Attendance

Johnson & Johnson

New Brunswick, NJ

jnj.com

Large pharma

Global healthcare company whose Innovative Medicine business develops and markets prescription drugs.

Talk

Mon Oct 26
10:00am–10:30am

Part of Symposium: Biodistribution and Persistence as the New Exposure Science for Gene & Cell Therapies: From Vectors to Living Drugs

Quantifying the “Living Drug”: Integrating Biodistribution, Expansion, and Persistence into Actionable Cellular Kinetics

206

Preclinical, Clinical, and Translational Sciences

Talk

Mon Oct 26
3:15pm–3:30pm

Part of Rapid Fire: Pushing the Boundaries of Hybrid LC-MS Bioanalysis

Multiplex Hybrid LC-MS for Four Monoclonal Antibody Therapeutics

203-205

Bioanalytics

Session

Tue Oct 27
9:00am–11:00am

Symposium: Oligonucleotide Bioanalysis: Ring Trial and Emerging Conjugate Modalities

Bioanalytics

Talk

Tue Oct 27
1:30pm–2:30pm

Keynote: Converging Platforms and Expanding Biological Insight

211-213

Bioanalytics

Instantly find 20 buyers from Johnson & Johnson

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the American Association of Pharmaceutical Scientists (AAPS). Submit a correction